Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Transplanting washed microbiota with nutritional support for gastroptosis

Official title: The Efficacy of WMT Combined With Nutritional Support in the Treatment of Malnutrition Complicated by Gastroptosis: A Real-World Study

Run by The Second Hospital of Nanjing Medical University · NCT06837194 · Data updated 2026-11-12

This study is testing if a new treatment using washed microbiota along with special nutrition can help adults with gastroptosis and malnutrition feel better.

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment24 (estimated)
SponsorThe Second Hospital of Nanjing Medical University
Academic / other
Locations1 site (Nanjing, Jangsu)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedFebruary 1, 2027
Study endsJuly 1, 2027
Registry record updatedFebruary 20, 2025
Trial IDNCT06837194 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with gastroptosis and meeting malnutrition criteria.

Probably not a fit

Patients with severe mental health issues that impair communication and treatment planning may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the efficacy and safety of washed microbiota transplantation (WMT) combined with enteral nutrition in patients diagnosed with gastroptosis and malnutrition. Participants will be monitored for their response to this combined treatment approach. The study will include adults who meet specific diagnostic criteria for gastroptosis and malnutrition, ensuring a focused examination of this patient population. The study will be conducted at The Second Hospital of Nanjing Medical University.

Why it matters

Potential benefit: If successful, this approach could improve nutritional status and overall health outcomes for patients suffering from gastroptosis and malnutrition.

How similar studies have gone: While the approach of washed microbiota transplantation is gaining interest, its combination with enteral nutrition for gastroptosis is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects must meet all of the following inclusion criteria to enter the study:

  1. Clinically diagnosed with gastroptosis;
  2. Meets the diagnostic criteria for malnutrition (fulfilling any one of the following two criteria):

     * Weight loss (weight loss \>5% within the last 6 months or \>10% over more than 6 months);

       * Low BMI (BMI \<18.5 kg/m² for individuals \<70 years old; BMI \<20 kg/m² for individuals ≥70 years old);
  3. Males aged ≥18 years and non-pregnant, non-lactating females aged ≥18 years;
  4. Willing to voluntarily sign a written informed consent form and agrees to follow medical advice for regular follow-up examinations and monitoring after the completion of treatment.

Exclusion Criteria:

* Subjects meeting any of the following exclusion criteria must be excluded from the study:

  1. Patients with severe depression, anxiety, or cognitive impairment that affects normal physician-patient communication and treatment planning;
  2. Patients with poor compliance who cannot accept treatment regimens such as nasogastric enteral nutrition;
  3. Anticipated survival time \<3 months;
  4. Clinically significant cardiovascular diseases, including heart failure (NYHA Class III-IV), uncontrolled coronary artery disease, cardiomyopathy, arrhythmia, history of myocardial infarction, hemodynamic instability at enrollment, unstable vital signs, or anticipated risk events during treatment;
  5. Poor pulmonary function deemed by investigators to impact study treatment (e.g., acute exacerbation of COPD or requirement for long-term oral/intravenous corticosteroids \[excluding inhaled corticosteroids\]);
  6. Active severe clinical infections (\> Grade 2 per NCI-CTCAE v5.0), including patients with intestinal fungal, viral, or tuberculosis infections;
  7. Inability to cooperate with intestinal tube placement or contraindications to intestinal tube placement;
  8. Use of medications affecting or modulating gut microbiota within the past 48 hours;
  9. Lack of legal capacity or restricted legal capacity;
  10. Hematologic disorders unsuitable for blood draw examinations;
  11. Other severe medical conditions deemed by investigators to preclude patient enrollment.

Where it's running

  • Department of Microbiota Medicine & Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
    Nanjing, Jangsu, China
    Recruiting

Study contacts

  • Principal investigator: Faming Zhang — The Second Hospital of Nanjing Medical University
  • Study coordinator: Faming Zhang, PhD
  • Email: fzhang@njmu.edu.cn
  • Phone: 086-025-58509883

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.